Advantages of Electro-deposited Gold on Carbon Electrodes for NT-proBNP Immunosensor for Development of Heart Failure Test Kit

Pongsakorn Aiemderm, Kanchana Monkhang, Sureeporn Wongjard, Kiattawee Choowongkomon, Napachanok Mongkoldhumrongkul Swainson, Chaiya Prasittichai, Charoenkwan Kraiya

Abstract

Accurate measurement of the N-terminal pro B-type natriuretic peptide (NT-proBNP) in serum is important for the diagnosis of heart failure (HF). Carbon screen-printed electrodes (SPCEs) modified with graphene oxide (GO) or gold (Au) were compared for the construction of NT-proBNP immunosensors. NT-proBNP and its recognition unit, a single-chain variable fragment fused with alkaline phosphatase (scFv-AP), were expressed and purified. The currents of the electrodes immobilized with scFv-AP were measured after adding an ethanolamine (ETA), blank and NT-proBNP in either phosphate buffer saline (PBS) or human serum. SPCE/Au had lower mean baseline slopes than for SPCE/GO for all measurements, in both PBS and serum, indicating greater accuracy for SPCE/Au. None of the measurements in PBS had statistically different peak currents between SPCE/GO and SPCE/Au; however, there was a significant difference with the serum. The significant reduction of SPCE/GO peak currents after applying serum blank implied non-specific absorption on the surface. The peak current of 300 pg/mL of NT-proBNP in the serum measured on SPCE/Au was significantly higher (by a factor of three) than on SPCE/GO, suggesting the possibility of using SPCE/Au to detect NT-proBNP at higher concentrations. The binding efficiency of scFv-AP to NT-proBNP did not depend on the electrodes, as shown by the similar delta peak-currents (Blank-Target). Thus, immobilized scFv-AP on SPCE/Au electrodes had good potential to accurately detect NT-proBNP in serum, for use in the fabrication of an HF test kit.

Keywords

References

[1] C. Mueller, K. McDonald, R. A. de Boer, A. Maisel, J. G. F. Cleland, N. Kozhuharov, A. J. S. Coats, M. Metra, A. Mebazaa, F. Ruschitzka, M. Lainscak, G. Filippatos, P. M. Seferovic, W. C. Meijers, A. Bayes-Genis, T. Mueller, M. Richards, and J. L. Januzzi Jr, “Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations,” European Journal of Heart Failure, vol. 21, no. 6, pp. 715–731, 2019.

[2] Y. Su Kim, N. Karisa, W. Y. Jeon, H. Lee, Y.-C. Kim, and J. Ahn, “High-level production of N-terminal pro-brain natriuretic peptide, as a calibrant of heart failure diagnosis, in Escherichia coli,” Applied Microbiology and Biotechnology, vol. 103, no. 12, pp. 4779–4788, 2019.

[3] M. Weber, V. Mitrovic, and C. Hamm, “B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide - Diagnostic role in stable coronary artery disease,” Experimental & Clinical Cardiology, vol. 11, no. 2, pp. 99–101, 2006.

[4] S. H. Wang, J. B. Zhang, Z. P. Zhang, Y. F. Zhou, R. F. Yang, J. Chen, Y. C. Guo, F. You, and X. E. Zhang, “Construction of Single Chain Variable Fragment (ScFv) and BiscFv-Alkaline phosphatase fusion protein for detection of bacillus anthracis,” Analytical Chemistry, vol. 78, no. 4, pp. 997–1004, 2006.

[5] S. Wongjard, P. Aiemderm, K. Monkhang, K. Jaengwang, L. Tabtimmai, C. Kraiya, K. Choowongkomon, and N. M. Swainson, “Selection, alkaline phosphatase fusion, and application of single-chain variable fragment (scFv) specific to NT-proBNP as electrochemical immunosensor for heart failure,” Heliyon, vol. 9, 2023, Art. no. e19710, doi: 10.1016/j.heliyon. 2023.e19710.

[6] N. M. Swainson, P. Aiemderm, C. Saikaew, K. Theeraraksakul, P. Rimdusit, C. Kraiya, S. Unajak, and K. Choowongkomon, “Biosensors for the detection of organophosphate exposure by a new diethyl thiophosphate-specific aptamer,” Biotechnology Letters, vol. 43, no. 9, pp. 1869–1881, 2021.

[7] Y. Liu and G. Dykstra, “Recent progress on electrochemical (bio)sensors based on aptamer-molecularly imprinted polymer dual recognition,” Sensors and Actuators Reports, vol. 4, 2022, Art. no. 100112.

[8] S. Campuzano, M. Pedrero, P. Yáñez-Sedeño, and J. M. Pingarrón, “New challenges in point of care electrochemical detection of clinical biomarkers,” Sensors and Actuators B: Chemical, vol. 345, 2021, Art. no. 130349.

[9] G. Paimard, E. Ghasali, and M. Baeza, “Screen-printed electrodes: Fabrication, modification, and biosensing applications,” Chemosensors, vol. 11, no. 2, 2023, Art. no. 113.

[10] A. G. Crevillen, A. Escarpa, and C. D. García, “Carbon-based nanomaterials in analytical chemistry,” in Handbook of Smart Materials in Analytical Chemistry. New Jersey: Wiley, pp. 345–374, 2019.

[11] M. Zidan, R. M. Zawawi, M. Erhayem, and A. Salhin, “Electrochemical detection of paracetamol using graphene oxide -modified glassy carbon electrode,” International Journal of Electrochemical Science, vol. 9, no. 12, pp. 7605–7613, 2014.

[12] J. Sethi, M. Van Bulck, A. Suhail, M. Safarzadeh, A. Perez-Castillo, and G. Pan, “A label-free biosensor based on graphene and reduced graphene oxide dual-layer for electrochemical determination of beta-amyloid biomarkers,” Microchimica Acta, vol. 187, no. 5, 2020, Art. no. 288.

[13] S. Guo and E. Wang, “Synthesis and electrochemical applications of gold nanoparticles,” Analytica Chimica Acta, vol. 598,no. 2, pp. 181–192, 2007.

[14] J. M. Pingarrón, P. Yáñez-Sedeño, and A. González-Cortés, “Gold nanoparticle-based electrochemical biosensors,” Electrochimica Acta, vol. 53, no. 19, pp. 5848–5866, 2008.

[15] S. Shikha, K. G. Thakur, and M. S. Bhattacharyya, “Facile fabrication of lipase to amine functionalized gold nanoparticles to enhance stability and activity,” RSC Advances, vol. 7, no. 68, pp. 42845– 42855, 2017.

[16] F. Zhang, S. Wang, and J. Liu, “Gold nanoparticles adsorb DNA and aptamer probes too strongly and a comparison with graphene oxide for biosensing,” Analytical Chemistry, vol. 91, no. 22, pp. 14743– 14750, 2019.

[17] A. G. Semenov, A. B. Postnikov, N. N. Tamm, K. R. Seferian, N. S. Karpova, M. N. Bloshchitsyna, M. I. Krasnoselsky, D. V. Serebryanaya, and A. G. Katrukha, “Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site,” Clinical Chemistry, vol. 55, no. 3, pp. 489–498, 2009.

[18] C. D. Martin, G. Rojas, J. N. Mitchell, K. J. Vincent, J. Wu, J. McCafferty, and D. J. Schofield, “A simple vector system to improve performance and utilisation of recombinant antibodies,” BMC Biotechnol, vol. 6, 2006, Art. no. 46.

[19] O. Amor-Gutiérrez, E. Costa-Rama, N. Arce- Varas, C. Martínez-Rodríguez, A. Novelli, M.T. Fernández-Sánchez, and A. Costa-García, “Competitive electrochemical immunosensor for the detection of unfolded p53 protein in blood as biomarker for Alzheimer's disease,” Analytica Chimica Acta, vol. 1093, pp. 28–34, 2020.

[20] M. Jakubowska, “Signal processing in electrochemistry,” Electroanalysis, vol. 23, no. 3, pp. 553–572, 2011.

[21] J. L. Januzzi, Jr, C. A. Camargo, S. Anwaruddin, A. L. Baggish, A. A. Chen, D. G. Krauser, R. Tung, R. Cameron, J. T. Nagurney, C. U. Chae, D. M. Lloyd-Jones, D. F. Brown, S. Foran- Melanson, P. M. Sluss, E.Lee-Lewandrowski, and K. B. Lewandrowski, “The N-terminal Pro- BNP investigation of dyspnea in the emergency department (PRIDE) study,” American Journal of Cardiology, vol. 95, no. 8, pp. 948–954, 2005.

Full Text: PDF

DOI: 10.14416/j.asep.2023.10.004

Refbacks

There are currently no refbacks.

Username
Password
Remember me